These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 28734619)

  • 1. Fibromyalgia: Prevalence, epidemiologic profiles and economic costs.
    Cabo-Meseguer A; Cerdá-Olmedo G; Trillo-Mata JL
    Med Clin (Barc); 2017 Nov; 149(10):441-448. PubMed ID: 28734619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology and sociodemographic characterization of the fibromyalgia in Comunidad Valenciana].
    Cabo-Meseguer A; Cerdá-Olmedo G; Trillo-Mata JL
    Rev Esp Salud Publica; 2019 Dec; 93():. PubMed ID: 31831726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Work, family and social environment in patients with Fibromyalgia in Spain: an epidemiological study: EPIFFAC study.
    Collado A; Gomez E; Coscolla R; Sunyol R; Solé E; Rivera J; Altarriba E; Carbonell J; Castells X
    BMC Health Serv Res; 2014 Nov; 14():513. PubMed ID: 25385047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, costs, and the economic burden of fibromyalgia.
    Spaeth M
    Arthritis Res Ther; 2009; 11(3):117. PubMed ID: 19591654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiological characteristics of patients evaluated with fibromyalgia in the Assessment of Disability Unit of Madrid].
    Regal Ramos RJ
    Semergen; 2017; 43(1):28-33. PubMed ID: 26858230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The social impact of Parkinson's disease in Spain: Report by the Spanish Foundation for the Brain.
    García-Ramos R; López Valdés E; Ballesteros L; Jesús S; Mir P
    Neurologia; 2016; 31(6):401-13. PubMed ID: 23816428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain.
    Mas AJ; Carmona L; Valverde M; Ribas B;
    Clin Exp Rheumatol; 2008; 26(4):519-26. PubMed ID: 18799079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain.
    Leadley RM; Armstrong N; Lee YC; Allen A; Kleijnen J
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):310-25. PubMed ID: 23216170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.
    Winkelmann A; Perrot S; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
    Appl Health Econ Health Policy; 2011 Mar; 9(2):125-36. PubMed ID: 21332254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
    Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic cost and epidemiological characteristics of patients with fibromyalgia claims.
    Robinson RL; Birnbaum HG; Morley MA; Sisitsky T; Greenberg PE; Claxton AJ
    J Rheumatol; 2003 Jun; 30(6):1318-25. PubMed ID: 12784409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of fibromyalgia: a survey in five European countries.
    Branco JC; Bannwarth B; Failde I; Abello Carbonell J; Blotman F; Spaeth M; Saraiva F; Nacci F; Thomas E; Caubère JP; Le Lay K; Taieb C; Matucci-Cerinic M
    Semin Arthritis Rheum; 2010 Jun; 39(6):448-53. PubMed ID: 19250656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
    Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
    Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review.
    Robinson RL; Jones ML
    Expert Opin Pharmacother; 2006 Jun; 7(8):1027-39. PubMed ID: 16722813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyalgia-related costs and loss of productivity: a substantial societal burden.
    Lacasse A; Bourgault P; Choinière M
    BMC Musculoskelet Disord; 2016 Apr; 17():168. PubMed ID: 27084363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study.
    Gharibpoor F; Nasrollahzadeh E; Ghavidel-Parsa B; Ghaffari ME; Bidari A
    Int J Rheum Dis; 2021 May; 24(5):671-680. PubMed ID: 33729682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and social costs of low back pain and fibromyalgia.
    de Girolamo G
    Clin J Pain; 1991; 7 Suppl 1():S1-7. PubMed ID: 1839774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss.
    White LA; Birnbaum HG; Kaltenboeck A; Tang J; Mallett D; Robinson RL
    J Occup Environ Med; 2008 Jan; 50(1):13-24. PubMed ID: 18188077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.